Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-09-21
1993-06-22
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514310, 514312, 514313, 514314, 546141, 546142, 546143, 546145, 546146, 546147, 546149, 546153, 546155, 546156, 546157, 546159, 546171, 546172, 546174, 546175, 546179, 546180, 546181, 546183, A61K 3147, C07D21722, C07D21724, C07D21516
Patent
active
052216772
ABSTRACT:
The invention concerns a heterocyclic derivative of the formula I ##STR1## wherein Q is an optionally substituted 6-membered monocyclic or 10-membered bicyclic heterocyclic moiety containing one or two nitrogen atoms;
REFERENCES:
patent: 3661917 (1972-05-01), Kaiser et al.
patent: 3743737 (1973-07-01), Kaiser et al.
patent: 4427680 (1984-01-01), Friebe et al.
patent: 4567184 (1986-01-01), Musser et al.
patent: 4625034 (1986-11-01), Neiss et al.
patent: 4631287 (1986-12-01), Chakraborty et al.
patent: 4725619 (1916-02-01), Chakraborty et al.
patent: 4728668 (1988-03-01), Chakraborty et al.
patent: 4794188 (1988-12-01), Musser et al.
patent: 4839369 (1989-06-01), Youssefyeh et al.
patent: 4876346 (1989-10-01), Musser et al.
patent: 4918081 (1990-04-01), Huang et al.
patent: 4920130 (1990-04-01), Huang et al.
patent: 4920131 (1990-04-01), Huang et al.
patent: 4920132 (1990-04-01), Huang et al.
patent: 4920133 (1990-04-01), Huang et al.
Crawley Graham C.
Edwards Philip N.
Gupta Y. N.
ICI Pharma
Imperial Chemical Industries plc
Shah Mukund J.
LandOfFree
5-lipoxygenase inhibitors quinoline or isoquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-lipoxygenase inhibitors quinoline or isoquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-lipoxygenase inhibitors quinoline or isoquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1441171